Clinical benefit of the gedatolisib regimens was consistent across patient subgroups Hyperglycemia was reported in only 9.2% of patients treated with gedatolisib + palbociclib + fulvestrant ...

The triplet regimen of berdomide, daratumumab (Darzalex), and dexamethasone has led to deepening responses in newly diagnosed, transplant-ineligible patients with multiple myeloma.

Anbenitamab combined with chemotherapy significantly improved PFS and OS in HER2-positive gastric or GEJ cancer patients compared to chemotherapy alone. The trial showed a 75% reduction in progression ...

The Baltimore Ravens are hoping they'll be a completely different team after their bye week break — with Lamar Jackson back ...

There were some potentially nerve-racking moments during Sunday’s matchup between the Packers and Bengals. But in the end, Green Bay did what it needed to do offensively throughout the second half, ...

The WNBA is leveling up—these five jaw-dropping practice facilities showcase the league’s investment in elite performance, wellness, and innovation. From skyline views to spa-grade recovery suites, ...

The 9.1.0.2 Patch for Destiny 2 has arrived, bringing with it dozens of updates and fixes to improve game balance, performance, and overall stability. This page acts as a comprehensive breakdown of ...

The stars are showing up for Europe so far at this 45th Ryder Cup. The Americans? Not so much. World No. 1 Scottie Scheffler and LIV standout Bryson DeChambeau went a combined 0-4 on Friday at ...

Mary Cunningham is a reporter for CBS MoneyWatch. Before joining the business and finance vertical, she worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program.

Final Fantasy 7 Remake is set to release on Switch 2 and Xbox next January and will come with boost features familiar to players of the Pixel Remasters, known as Streamlined Progression. Square Enix ...

A global clinical trial for a new Huntington’s disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL scientists. The researchers found that patients receiving ...